Alnylam Pharmaceuticals (ALNY): Director sold ~$3.09M

~$3.09M

Approx. value · 11K sh @ $275.00

Traded

Jan 23, 2025

Filed

Jan 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 26, 2024Insider · 5 peopleInsiders: 25 sales (~$2.9M)
2. Nov 27, 2024Insider · 1 personInsiders: 4 sales (~$386K)
3. Dec 12, 2024Insider · 1 personInsiders: 7 sales (~$440K)
4. Jan 23, 2025 · this disclosureInsiderDirector sold ~$3.09M of ALNY shares in the open market

What came next

1. Jan 27, 2025InsiderOfficer sold ~$15M of ALNY shares in the open market
2. Feb 14, 2025Insider · 3 peopleInsiders: 31 sales (~$783K)
3. Feb 18, 2025Insider · 2 peopleInsiders: 11 sales (~$752K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alnylam Pharmaceuticals

For Alnylam Pharmaceuticals, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALNY page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Alnylam Pharmaceuticals

• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 144Oct 2, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its ALNY page.